Quantum Consciousness Dispatch #2 INTRODUCTION Among many theories of developmental psychology (Maslow, Graves et al), the creation of a similar theory by Timothy Leary was mostly lost in the noise of his phases as a guru in the 60’s, and then a criminal fugitive in the early 70’s. But Leary…

The Non-Pharma Landscape — Big Clinical Players AFAIK Dispatch #8 Alzheimer’s Families for Action, Innovation and Knowledge Introduction I have taken the position in this AFAIK series that pharmacological treatments for Alzheimer’s Disease and other forms of cognitive decline see an overwhelming majority of funding and attention relative to neurostimulation approaches. …

Epigenetics Dispatch #2 — Don Dulchinos — neurosphere.org Introduction In an earlier article, I tried to bring developmental psychology theories up to date by proposing a biological mechanism driving movement across levels of existence (Clare Graves) or circuits (Tim Leary and Robert Anton Wilson); namely, the development of the science…

AFAIK Dispatch #7 Alzheimer’s Families for Action, Innovation and Knowledge My mother-in-law, Frances Bigda, passed away recently, from complications of Alzheimer’s Disease and the flu. She was very intelligent, cultivated an active physical and intellectual life, and had a life-long teaching career culminating in becoming a high-school principal. She was…

The Consumer Electronics Show never gets old for me, so here’s this year’s neurotech summary. I was even more excited this year as I am assisting with the launch of a Consumer Technology Association effort to standardize consumer EEG technology — quite a few exhibiting companies are supporting this effort…

PUBLICATION ARCHIVE ALZHEIMER’S FAMILIES FOR ACTION, INFORMATION AND KNOWLEDGE AFAIK Dispatch #1 AFAIK Dispatch #2 — Pharma and the FDA AFAIK Dispatch #3 — Cognito News Item AFAIK Dispatch #4 — Neurostim at the End of the Tunnel? AFAIK Dispatch #5 — Good News, Bad News AFAIK Dispatch #6 — #BigAlzheimer’sFail AFAIK Dispatch #7 — Granny, the Past and the Future AFAIK Dispatch #8 — The Non-Pharma Landscape — Big Clinical Players

AFAIK Dispatch #6 — Alzheimer’s Families for Action, Innovation and Knowledge As seen in previous Dispatches, pharma is an easy target to criticize. But they have enablers. One is the investment community, which is in business to get returns, not to make moral choices. Another is journalistic channels of information…

AFAIK Dispatch #6 Alzheimer’s Families for Action, Innovation and Knowledge As seen in previous Dispatches, pharma is an easy target to criticize. But they have enablers. One is the investment community, which is in business to get returns, not to make moral choices. Another is journalistic channels of information, where…

AFAIK Dispatch #5 Alzheimer’s Families for Action, Innovation and Knowledge Recent news items have not done much (yet) to change my mind about the dismal state of Alzheimer’s Disease (AD) treatments, nor the FDA, Medicare and the pharmaceutical industry dance. Some recent news below. But also, some good news on…